resiquimod has been researched along with lipid a in 10 studies
| Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) | Studies (lipid a) | Trials (lipid a) | Recent Studies (post-2010) (lipid a) |
|---|---|---|---|---|---|
| 465 | 14 | 318 | 3,901 | 125 | 1,143 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fraillery, D; Nardelli-Haefliger, D; Zosso, N | 1 |
| Dietsch, GN; Dowling, DJ; Hershberg, RM; Levy, O; Matthews, MA; Palmer, CD; Prokopowicz, ZM; Tan, Z | 1 |
| Carter, D; Chung, NP; Klasse, PJ; Matthews, K; Moore, JP; Moutaftsi, M; Reed, SG; Salazar, AM; Sanders, RW | 1 |
| Baldwin, SL; Clifford, D; Coler, RN; Ireton, GC; Jones, GJ; Reed, SG; Steinbach, S; Vordermeier, HM | 1 |
| Barinaga, G; Carter, D; King, DF; Mann, JF; McKay, PF; Shattock, RJ | 1 |
| Ahmed, S; Bergelson, I; Berger, ST; Brightman, S; Choi, H; Dowling, DJ; Kho, AT; Levy, O; Oh, DY; Pettengill, M; Pollack, HJ; Sauld, JF; Steen, H | 1 |
| Niknam, HM; Rostamian, M | 1 |
| Ehrich, M; Harmon, T; Harris, B; Hu, Y; Pentel, PR; Zhang, C; Zhao, Z | 1 |
| Bahrami, F; Niknam, HM; Rostamian, M | 1 |
| Bagola, K; Bastian, M; David-Watine, B; Gerards, AL; Hasan, M; Kamp, C; Roßmann, L; Schülke, S; Shorte, SL; Spreitzer, I; Stephen, T; Ullrich, A; van Zandbergen, G; Walber, B | 1 |
10 other study(ies) available for resiquimod and lipid a
| Article | Year |
|---|---|
Rectal and vaginal immunization of mice with human papillomavirus L1 virus-like particles.
Topics: Adjuvants, Immunologic; Administration, Intravaginal; Administration, Rectal; Animals; Antibodies, Viral; Antibody Formation; Capsid Proteins; Cholera Toxin; Female; Human papillomavirus 16; Humans; Imidazoles; Lipid A; Mice; Mouth; Nonoxynol; Oncogene Proteins, Viral; Papillomavirus Infections; Papillomavirus Vaccines; Rectum; Vaccines, Synthetic; Vagina | 2009 |
The ultra-potent and selective TLR8 agonist VTX-294 activates human newborn and adult leukocytes.
Topics: Adult; Analysis of Variance; Benzazepines; Dendritic Cells; Flow Cytometry; HEK293 Cells; Humans; Imidazoles; Infant, Newborn; Leukocytes; Lipid A; Quinolines; Thiazoles; Toll-Like Receptor 8 | 2013 |
Clinical adjuvant combinations stimulate potent B-cell responses in vitro by activating dermal dendritic cells.
Topics: Adjuvants, Immunologic; Adult; Aged; B-Lymphocytes; Carboxymethylcellulose Sodium; Cell Polarity; Cell Proliferation; Cells, Cultured; Coculture Techniques; Cytokines; Drug Synergism; HIV Envelope Protein gp120; Humans; Imidazoles; Langerhans Cells; Lipid A; Lipopolysaccharide Receptors; Lymphocyte Activation; Middle Aged; Poly I-C; Polylysine; Skin; Toll-Like Receptors; Vaccination; Young Adult | 2013 |
Immunisation with ID83 fusion protein induces antigen-specific cell mediated and humoral immune responses in cattle.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Bacterial; Antigens, Bacterial; Cattle; Cell Proliferation; Imidazoles; Immunity, Cellular; Immunity, Humoral; Immunoglobulin G; Interferon-gamma; Leukocytes, Mononuclear; Lipid A; Mycobacterium bovis; Recombinant Fusion Proteins; Tuberculosis Vaccines; Tuberculosis, Bovine; Vaccines, Subunit; Vaccines, Synthetic | 2013 |
TLR4 and TLR7/8 Adjuvant Combinations Generate Different Vaccine Antigen-Specific Immune Outcomes in Minipigs when Administered via the ID or IN Routes.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Adjuvants, Immunologic; Administration, Intranasal; AIDS Vaccines; Animals; Antibody Affinity; Antibody Specificity; Antigens; Dose-Response Relationship, Immunologic; Drug Combinations; env Gene Products, Human Immunodeficiency Virus; Female; HIV Antibodies; Imidazoles; Immunity, Innate; Immunity, Mucosal; Immunization, Secondary; Immunoglobulin G; Injections, Intradermal; Lipid A; Models, Animal; Nasal Mucosa; Neutralization Tests; Organ Specificity; Swine; Swine, Miniature; Toll-Like Receptor 4; Toll-Like Receptor 7; Toll-Like Receptor 8; Vaccination; Vagina | 2016 |
Adjuvant-induced Human Monocyte Secretome Profiles Reveal Adjuvant- and Age-specific Protein Signatures.
Topics: Adjuvants, Immunologic; Adult; Age Factors; Alum Compounds; Chromatography, Liquid; Humans; Imidazoles; Immunity, Innate; Infant, Newborn; Lipid A; Mass Spectrometry; Monocytes; Proteome; Proteomics | 2016 |
Evaluation of the adjuvant effect of agonists of toll-like receptor 4 and 7/8 in a vaccine against leishmaniasis in BALB/c mice.
Topics: Adjuvants, Immunologic; Animals; Antigens, Protozoan; Hypersensitivity, Delayed; Imidazoles; Interferon-gamma; Interleukin-10; Leishmania major; Leishmaniasis Vaccines; Leishmaniasis, Cutaneous; Lipid A; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Toll-Like Receptor 4; Toll-Like Receptor 7; Toll-Like Receptor 8 | 2017 |
Rational incorporation of molecular adjuvants into a hybrid nanoparticle-based nicotine vaccine for immunotherapy against nicotine addiction.
Topics: Adjuvants, Immunologic; Animals; Imidazoles; Immunotherapy; Lipid A; Mice; Nanoparticles; Nicotine; Oligodeoxyribonucleotides; Tobacco Use Disorder; Vaccines | 2018 |
Vaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB/c mice.
Topics: Adjuvants, Immunologic; Animals; Antigens, Protozoan; Cytokines; Disease Models, Animal; Female; Imidazoles; Leishmania tropica; Leishmaniasis; Leishmaniasis Vaccines; Lipid A; Mice, Inbred BALB C; Parasite Load; Protozoan Proteins; Random Allocation; Recombinant Proteins; Toll-Like Receptors; Vaccination; Vaccines, Inactivated | 2018 |
Distinct single-component adjuvants steer human DC-mediated T-cell polarization via Toll-like receptor signaling toward a potent antiviral immune response.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; COVID-19; Dendritic Cells; Female; Humans; Imidazoles; Immunity, Cellular; Lipid A; Male; Middle Aged; SARS-CoV-2; T-Lymphocytes; Toll-Like Receptors | 2021 |